finding the key to better outcomes in flt3-mutated aml
Published 1 year ago • 466 plays • Length 29:51Download video MP4
Download video MP3
Similar videos
-
4:32
improving outcomes in flt3-mutated aml patients
-
1:28:16
maintaining “intensity” for better outcomes in aml
-
6:18
previously untreated flt3-mutated aml
-
1:12
gilteritinib relapse leads to loss of flt3-tkd mutation in patient with aml
-
1:06
investigating the molecular and clinical features of flt3-jmd mutations in aml
-
39:50
flt3 inhibitors in the therapy of acute myeloid leukemia
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
1:16
mechanisms of resistance to the tki asciminib in cml
-
2:14:40
a master class on building better therapy for aml
-
6:47
the 2021 treatment algorithm for flt3-mutated aml
-
0:49
treatment avenues for patients with r/r flt3-mutated aml: optimizing flt3 inhibitors
-
1:33:16
the advantage of innovation in aml
-
2:28
dr. levis on gilteritinib in relapsed/refractory flt3-mutated aml
-
1:21
gemtuzumab-based induction chemotherapy with midostaurin in flt3-mutated aml
-
17:43
aml: what to do with your 500-gene mutation report
-
1:50
mark levis, md, on why the flt3 target is important in aml
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
0:58
flt3 mutation clearance rate in patients with newly diagnosed aml
-
1:28
patient-reported outcomes in flt3-mutated aml patients treated with gilteritinib plus azacitidine